Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis | Zendy

Leyla Asadi | Zendy; Wendy Sligl | Zendy; Dean T. Eurich | Zendy; Isabelle N Colmers-Gray | Zendy; Lisa Tjosvold | Zendy; Thomas J. Marrie | Zendy; Sumit R. Majumdar | Zendy

Open Access

Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

Author(s) -

Leyla Asadi,

Wendy Sligl,

Dean T. Eurich,

Isabelle N Colmers-Gray,

Lisa Tjosvold,

Thomas J. Marrie,

Sumit R. Majumdar

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis414

Subject(s) - medicine , community acquired pneumonia , pneumonia , confidence interval , guideline , relative risk , randomized controlled trial , antibiotics , macrolide antibiotics , intensive care medicine , erythromycin , pathology , microbiology and biotechnology , biology

Macrolides are used to treat pneumonia despite increasing antimicrobial resistance. However, the immunomodulatory properties of macrolides may have a favorable effect on pneumonia outcomes. Therefore, we systematically reviewed all studies of macrolide use and mortality among patients hospitalized with community-acquired pneumonia (CAP).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research